New [18F]-FES PET/CT imaging to detect and describe endometriosis lesions
Official title: 18F]-FES PET in the Detection and Characterization of Endometriosis Lesions
Run by University Hospital, Toulouse · NCT07053982 · Data updated 2026-11-12
This study will test whether an [18F]-FES PET/CT scan can better find endometriosis lesions and measure estrogen receptor activity in adults scheduled for surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | March 23, 2026 |
| Main results expected | March 2028 |
| Study ends | March 2028 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT07053982 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 undergoing surgery for endometriosis who can have a preoperative MRI and [18F]-FES PET/CT, are not menopausal or on hormone therapy, and can provide informed consent are ideal candidates.
✕Probably not a fit
Patients who are pregnant, menopausal, currently on hormone therapy, managed without surgery, claustrophobic, or allergic to the tracer are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants will undergo a preoperative [18F]-FES PET/CT scan in addition to standard MRI, with images compared to surgical and pathology findings to locate and characterize lesions. The study will correlate PET uptake with tissue estrogen receptor expression measured on surgical specimens and with patient-reported pain intensity. Enrollment includes symptomatic cases (VAS ≥ 4) and control patients treated surgically for infertility (VAS < 4), with imaging performed mid-cycle when possible. The approach aims to determine whether [18F]-FES PET/CT improves lesion detection and provides quantitative receptor information that could guide treatment.
Why it matters
Potential benefit: If successful, the test could improve diagnostic accuracy, shorten diagnostic delay, and help personalize hormonal treatment by showing lesion estrogen receptor expression.
How similar studies have gone: [18F]-FES PET/CT has shown good correlation with estrogen receptor expression in breast cancer, but its application to endometriosis is novel and data are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Cases: \- Painful patients with a VAS ≥ 4 treated surgically for painful symptoms related to endometriosis; Controls: * Patient with a VAS \< 4 treated surgically for endometriosis in the context of infertility; * Age \> 18 years; * Patient who provided informed consent; * Patients who underwent a preoperative MRI and were not contraindicated for \[18F\]-FES PET/CT; * Patient who underwent surgery mid-cycle; * Affiliation to a social security scheme Exclusion Criteria: * Patient treated for endometriosis without surgery; * Pregnant patient * Patient taking hormone therapy * Menopausal patient * Hypersensitivity to the active substance (Fluoroestradiol (18F)) or to any of the excipients * Patient under legal protection * Claustrophobic patient
Where it's running
-
Toulouse, Rangueil Hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Ariane WEYL, MD — University Hospital, Toulouse
- Study coordinator: Ariane Weyl
- Email: weyl.a@chu-toulouse.fr
- Phone: 05 61 32 21 48
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.